BRIEF-Pfizer Canada says Health Canada has given conditional approval of IBRANCE TM

Tue May 10, 2016 8:29am EDT
 
Email This Article |
Share This Article
  • Facebook
  • LinkedIn
  • Twitter
| Print This Article
[-] Text [+]

May 10 (Reuters) - Pfizer Canada

* Health Canada has provided conditional approval of IBRANCE TM (palbociclib) and it is now available in canada Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +1 646 223 8780)